ALZHEIMER DISEASE

This study is testing whether combining two types of drugs works better than one to slow cognitive decline in early Alzheimer's disease or mild cognitive impairment. Researchers will give 80 participants a drug that affects brain signaling (an NMDA-enhancing agent) plus an antiox…

This study is testing whether two different exercise programs—cardio-dance fitness versus strength, flexibility, and balance training—can improve brain health and reduce Alzheimer's disease risk in older African Americans. Researchers will enroll 280 sedentary adults aged 60+ to …

This small pilot study is testing whether a new probiotic formula (SCV09) can improve behavioral symptoms and daily functioning in people with Alzheimer's disease. Researchers are exploring the connection between gut health and brain function. The study will enroll 30 participant…

This study is testing whether a small neck surgery can temporarily improve thinking and daily function in people with Alzheimer's disease. The surgery aims to help drain fluid from the brain. Researchers will compare the real surgery to a sham procedure in 50 patients to see if t…

This study continues testing an experimental treatment called SNK01 for Alzheimer's disease to check its long-term safety and see if it might help with thinking and memory. It's for 30 people who already completed an earlier study of the same treatment. Participants receive SNK01…

This study is testing an oral drug called Senicapoc to see if it can slow down the progression of Alzheimer's disease in people with early memory problems. About 55 participants will take either the drug or a placebo daily for one year. Researchers will measure changes in memory,…

This study is testing whether a specific blend of dietary supplements can help improve brain function in people with Alzheimer's disease. About 845 participants will take either the supplement capsules or a placebo twice a day for 26 weeks. Researchers will measure changes in mem…

This study is testing whether a non-invasive magnetic brain stimulation treatment can help people with mild Alzheimer's disease. Researchers will target a part of the brain called the cerebellum to see if it improves memory, thinking skills, and the ability to perform daily activ…

This study tests a new, non-invasive brain stimulation treatment for people with mild Alzheimer's disease. Researchers will use a combination of magnetic and electrical pulses, targeted to specific brain networks, to try to slow the progression of memory and thinking problems. Th…

This study is testing a new virtual care program designed to help veterans with early Alzheimer's disease or memory problems get diagnosed and access new treatments more quickly. The program uses telehealth visits, advanced brain scans, and streamlined paperwork to reduce wait ti…

This study is testing whether adding a special near-infrared light therapy to the approved Alzheimer's drug lecanemab is safe and more effective at controlling the disease. It will involve 20 people with mild Alzheimer's. For 16 weeks, half will get the real light therapy with th…

This large, real-world study aims to see if adding the drug donanemab to usual care helps people with early Alzheimer's disease maintain their independence longer than usual care alone. It will follow about 6,250 participants for over five years, tracking how long they can live a…

This early-stage study is testing a new drug called ARO-MAPT-SC to see if it is safe and how it behaves in the body. It will involve both healthy volunteers and people with early Alzheimer's disease. The main goal is to find a safe dose and understand the drug's effects before te…

This study is testing whether a form of vitamin B1 called benfotiamine can slow down the worsening of memory and daily function in people with early Alzheimer's disease. Over 400 participants will take either the study drug or a placebo for 18 months to see if it is safe and effe…

This UCLA study is testing whether a non-invasive brain stimulation technique can help improve memory in people with mild-to-moderate Alzheimer's disease. Researchers will use a device that delivers magnetic pulses to a specific brain area to see if it's safe, tolerable, and show…

This early-stage study is testing whether a new drug called NIO752 can reduce the brain's production of tau protein, which forms toxic tangles in Alzheimer's disease. Researchers will give the drug via spinal injection to 10 participants with mild to moderate Alzheimer's and meas…

This study is testing whether a focused ultrasound device can safely and temporarily open the blood-brain barrier in people with Alzheimer's disease. The goal is to see if this opening could allow future treatments to better reach the brain. Up to 30 participants will receive thr…

This study is testing whether a drug called siponimod, already approved for multiple sclerosis, can slow the progression of mild Alzheimer's disease. About 105 participants will take either the drug or a placebo for one year, followed by a six-month observation period. The main g…

This study is testing whether restricting eating to a 10-hour window each day (fasting for 14 hours overnight) can help slow cognitive decline in people with mild cognitive impairment or early Alzheimer's disease. Researchers will enroll 60 older adults to follow this eating patt…

This study is testing whether the drug donanemab is safe and effective at slowing the progression of early Alzheimer's disease. It will involve about 1,500 people who have mild memory problems and confirmed Alzheimer's-related brain changes. Participants will receive either the d…

This study is testing whether a special balance therapy can help prevent falls in people with mild-to-moderate Alzheimer's disease. Researchers will work with 100 participants who have both Alzheimer's and inner-ear balance problems. The therapy involves weekly sessions and daily…

This study is testing if a gentle, non-invasive electrical stimulation to the brain can help improve memory in people with Alzheimer's disease. Researchers believe memory problems may be linked to poor coordination between different brain areas, and this stimulation aims to help …

This small, early-stage study is testing whether a drug called galcanezumab, currently used for migraines, can help people with mild-to-moderate Alzheimer's disease. Ten participants will receive injections of the drug every four weeks for six months. Researchers will measure cha…

This study is testing a new program in nursing homes to improve how suspected infections are managed in residents with dementia. It aims to see if the program can safely reduce the use of antibiotics and avoid stressful hospital trips and tests. The study will involve about 750 r…

This study is testing whether a caregiver can safely use a home-based, non-invasive brain stimulation device to help improve memory, thinking, and walking in older adults with mild dementia or memory loss. Participants and their caregivers will be trained to use the device at hom…

This study is testing if a safe, existing water pill called bumetanide might help control Alzheimer's disease. It will check the pill's safety and see if it improves thinking skills in 40 people with early Alzheimer's. The research is based on promising data suggesting the drug c…

This study aims to closely watch 120 people with early Alzheimer's disease who are taking the drug lecanemab. Researchers will track changes in their brain scans, memory, thinking, and daily life over 18 months to see how well the drug works and monitor for any side effects. The …

This study is testing whether a drug called rapamycin, taken daily for a year, is safe and might help slow down memory and thinking problems in older adults with early-stage Alzheimer's disease or mild cognitive impairment. Researchers will enroll 40 participants to measure chang…

Researchers are testing if a drug called sargramostim, already approved for other uses, is safe and might help people with mild-to-moderate Alzheimer's disease. The 6-month study with 42 participants will check if the drug can slow or stop cognitive decline and improve daily func…

This is the first human study of a new capsule called J4 being developed for Alzheimer's disease. Researchers are testing it in 76 healthy adults to check if it's safe and to understand how the body processes it. The study will give participants either the drug or a placebo in in…

This early-stage study is testing the safety of a new drug called LY3954068 for people with early Alzheimer's symptoms. The drug is given as an injection into the spinal fluid. Researchers will check how the body processes the drug and look for any side effects in 48 participants…

This German study is checking the safety of a non-invasive brain stimulation treatment called Transcranial Pulse Wave Stimulation (TPS) for people with Alzheimer's disease. It will follow 100 patients to watch for any side effects and see if the treatment helps with memory, mood,…

This study is testing a new surgical procedure for people with mild to moderate Alzheimer's disease. Doctors will perform a neck surgery to create a bypass, aiming to help the brain drain away harmful proteins thought to cause the disease. The main goal is to check if the surgery…

This study is testing whether adding acupuncture to the standard Alzheimer's medication donepezil can better help patients with mild to moderate symptoms. It will involve 180 people who will either receive the medication alone or the medication plus acupuncture three times a week…

This study is testing whether a medication called levetiracetam, commonly used for seizures, can prevent epileptic seizures in adults with Down syndrome who also have Alzheimer's disease. Researchers also want to see if the drug can slow down the brain changes and memory loss lin…

This study is testing whether a prescription sleep aid called lemborexant can reduce levels of proteins linked to Alzheimer's disease in the body. It will involve about 200 older adults who have early signs of Alzheimer's but no memory problems yet. Researchers will measure prote…

This early study is testing whether a gentle, focused ultrasound device can safely be used to stimulate the brain in people with early memory loss due to Alzheimer's disease. The goal is to see if this non-invasive approach can improve brain function and slow decline. Researchers…

This study is testing whether a non-invasive brain stimulation technique, combined with memory training, can help improve thinking skills in older adults who are worried about their memory and have a family history of Alzheimer's disease. About 30 participants will receive either…

This early-stage study is testing the safety and side effects of a new Alzheimer's drug called LY4006895. Researchers will give the drug to healthy volunteers and people with early memory problems from Alzheimer's disease to see how their bodies handle it. The study will measure …

This study aims to determine whether a newer type of brain scan (tau-PET) is more helpful for doctors than the current standard scan (amyloid-PET) when diagnosing Alzheimer's disease. It will involve 120 people aged 50-85 who have mild memory problems or early-stage dementia. Res…

This large study aims to find early signs of Alzheimer's disease by looking at blood, genes, and brain scans. Researchers will follow 6,000 older adults in China for five years to identify markers that can spot the disease sooner. The goal is to create a test kit for early diagno…

This study is testing a new, brief iPad-based tool called MyCog to help primary care doctors detect early signs of memory loss and dementia more effectively. It focuses on helping older adults from Black, Hispanic/Latino, and low-income communities who often face delays in diagno…

This study is testing a new eye scan to see if it can detect signs of Alzheimer's disease in the retina. Researchers will give a single injection of a special dye (AMDX-2011P) to 25 people with confirmed Alzheimer's and then take detailed pictures of their eyes. The main goals ar…

This study aims to find a new, easier way to diagnose Alzheimer's disease. Researchers will collect small tear samples from 90 people, including those with Alzheimer's and healthy volunteers. They will check if certain proteins and other substances in tears can reliably indicate …

This study is testing a new digital platform designed to detect very early signs of Alzheimer's disease. Researchers will use non-invasive tools like brain wave monitors and eye-tracking devices on 100 participants, some with mild memory concerns and some healthy, over 12 months.…

This study is testing a new type of brain scan (called [18F]PI-2620 PET imaging) to see how accurately it can detect the tau protein linked to Alzheimer's disease in people while they are alive. It will enroll about 200 people, including those with Alzheimer's and healthy control…

This study is exploring whether changes in how people use their smartphones could serve as an early warning sign for Alzheimer's disease. Researchers will collect three months of smartphone data from 90 people: some with memory complaints, some with mild cognitive decline, and so…

This study is testing a blood test to see if it can help doctors find Alzheimer's disease earlier in people who are hospitalized for sudden confusion or memory problems. Researchers will enroll 30 hospitalized patients aged 60-90 who have no prior dementia diagnosis. The main goa…

This study is testing whether a daily supplement made from flaxseed oil (a source of alpha-linolenic acid, or ALA) can help protect brain health and slow memory decline. It is for adults aged 60+ who have mild memory problems and carry a specific gene (APOE4) linked to higher Alz…

This study is testing whether a prescription sleep medication called suvorexant can slow down the buildup of a harmful protein in the brain that is linked to Alzheimer's disease. Researchers will enroll 200 healthy adults aged 65 and older who have normal memory. The main goal is…

This study tests if involving family members in a proven hospital care program is better at preventing delirium (sudden, severe confusion) in older patients. It will compare the standard Hospital Elder Life Program (HELP) with a new version that trains and includes family caregiv…

This study is testing whether a weight loss program can help prevent or delay Alzheimer's disease in adults with Down syndrome. 81 adults with Down syndrome who are overweight but do not have dementia will be assigned to either a weight loss group or a general health education gr…

This study aims to see if people with mild Alzheimer's disease can learn and remember skills to prevent dangerous falls. Researchers will give one group special balance training using controlled pushes on a treadmill, while another group gets no training. They will then track how…

This study is testing whether a mobile app called Brain CareNotes can help reduce stress for people caring for loved ones with Alzheimer's disease. Researchers will compare the app against a basic education app over 12 months with 184 caregiver participants. The goal is to see if…

This study is testing a new support program for people with Alzheimer's or dementia and their caregivers during the transition from a nursing facility to home or another care setting. The program provides extra help and education to nursing facility staff and assigns a specialist…

This study is testing whether a new oral medication called BMS-986368 can safely reduce agitation in people with Alzheimer's disease. About 120 participants will be randomly assigned to receive either the drug or a placebo to compare the effects. The main goal is to see if the dr…

This study is testing whether a new oral medication called IGC-AD1, which contains THC (the main active compound in cannabis) and melatonin, can safely reduce agitation in people with Alzheimer's disease. It will involve about 164 participants aged 60 and older who have significa…

This study is testing whether a combination of two medications called KarXT and KarX-EC can safely reduce agitation in people with Alzheimer's disease. The trial will involve 352 adults with Alzheimer's who experience significant agitation, comparing the active treatment to a pla…

This study is testing whether nabilone, a synthetic drug similar to cannabis, can safely and effectively treat agitation in people with Alzheimer's disease. Agitation is a common and distressing symptom that speeds up the need for nursing home care and increases caregiver stress.…

This small pilot study is testing whether combining two painless, non-invasive brain stimulation techniques can help manage difficult behavioral and emotional symptoms in people with Alzheimer's disease. The study aims to see if the treatment process is practical for patients and…

This study is testing a phone-based training program called PICT for family caregivers of people with Alzheimer's or related dementias. The program teaches caregivers how to spot signs of pain in their loved ones and how to talk about it effectively with healthcare providers. Res…

This study is testing whether CBD (cannabidiol) capsules can help reduce agitation in people with Alzheimer's disease. Forty participants will try both CBD and a placebo pill in a random order over 19 weeks to see which works better. Researchers will measure changes in agitation,…

This study is testing whether a gentle, non-invasive brain stimulation technique can improve symptoms like memory loss and confusion in people with Alzheimer's disease, Lewy body dementia, and other related conditions. Researchers will compare the effects of real stimulation to a…

This study is testing whether providing hearing aids and communication support to older adults with both Alzheimer's disease and hearing loss can reduce distressing symptoms like agitation and improve their relationship with their caregiver. Researchers will enroll 300 participan…

This study is testing a text message support program called CuidaTEXT for Latino caregivers of family members with Alzheimer's or related dementias. Researchers want to see if receiving daily tips, education, and encouragement via text can help reduce caregivers' feelings of depr…

This study is testing a non-invasive brain stimulation treatment for depression in people over 60 who have Alzheimer's disease or mild memory loss. Participants who haven't been helped by antidepressant medications will receive daily magnetic stimulation sessions for four weeks. …

This study aims to understand the long-term safety and side effects of two drug combinations, KarXT and KarX-EC, for treating agitation in people with Alzheimer's disease. It is open to 600 participants who have already completed one of two previous related studies. The main goal…

This study is testing whether a medication called KarXT can safely reduce distressing psychosis symptoms like hallucinations and delusions in people with Alzheimer's disease. It will involve about 406 adults aged 55-90 who have been diagnosed with Alzheimer's and have experienced…

This study is testing whether a program of enjoyable outdoor activities, like gardening or walking a dog, is practical and liked by people with memory challenges and their care partners. Researchers want to see if this 'Green Activity Program' helps people stay active and improve…

This study is testing whether a combination of two medications, KarXT and KarX-EC, can safely reduce agitation in people with Alzheimer's disease. The trial will involve 352 adults who experience significant agitation related to their Alzheimer's. Participants will receive either…

This study is testing a new 3D calendar tool designed to help people with mild to moderate Alzheimer's or dementia who get confused about the time, date, or season. Researchers will observe 20 hospitalized patients to see if using the tool daily helps them stay oriented. The main…

This study is testing whether a two-part treatment can help reduce apathy, a common loss of motivation, in people with Alzheimer's disease. Researchers are combining a stimulant medication (methylphenidate) with a gentle, non-invasive brain stimulation technique. The goal is to s…

This small, early-stage study from Johns Hopkins University is testing whether the psychedelic compound psilocybin, given in a controlled setting with support, can safely reduce depression in people with mild cognitive impairment or early Alzheimer's disease. Up to 20 participant…

This study is testing whether a home-based brain stimulation device can help improve mood, anxiety, and apathy in people with Alzheimer's disease. Researchers are enrolling 24 older adults with Alzheimer's and their caregivers to use the device at home for 30-minute sessions. The…

This study is testing a new way to teach family caregivers of people with dementia. It compares a special learning method that uses practice quizzes to a traditional reading approach. The goal is to see if the new method helps caregivers remember information better, feel more con…

This study is testing a smartphone app called 'Brain CareNotes' to see if it helps people caring for family members with dementia in rural areas. The app is designed to reduce caregiver stress and help manage difficult dementia-related behaviors. Researchers will compare the app …

This study is testing if a common pain medication (oxycodone/acetaminophen) is safe and effective for treating chronic pain in people who have Alzheimer's disease. It will involve 10 participants who will take the medication daily for 12 weeks. Researchers will track changes in p…

This study is testing if a special computer-based program can help reduce anxiety and stress in older adults with early-stage memory loss or mild Alzheimer's disease. It also looks at whether the program helps reduce the strain on their family caregivers. Researchers will compare…

This study is testing a 6-week online skills training program for family members caring for someone with Alzheimer's or another dementia. The program, called Learning Skills Together, teaches practical care tasks and coping strategies. Researchers want to see if it helps caregive…

This study is testing whether a new drug called MK-1167, when added to standard Alzheimer's medication, can help improve memory, thinking, and daily function for people with mild to moderate Alzheimer's dementia. Researchers will compare the effects of MK-1167 against a placebo i…

This study is testing whether gentle light and sound stimulation at a specific frequency (40Hz) can change brain activity in healthy adults and people with Alzheimer's disease. Researchers want to see if this non-invasive approach is safe and affects brain connections, thinking s…

This study aims to see if specific blood tests can accurately track how well the Alzheimer's drug lecanemab is working. Researchers will observe 400 patients in China with early Alzheimer's who are already taking lecanemab. They will collect blood samples and brain scans over 18 …

This study is testing a new type of brain scan to measure a protein called fibrin in people with and without Alzheimer's disease. Researchers want to see if there are differences in fibrin levels between healthy individuals and those with memory problems. The goal is to better un…

This study aims to understand if speech therapy tailored for bilingual people can help those with primary progressive aphasia, a condition that causes worsening language problems. Researchers will test 60 bilingual participants to see if practicing in both their languages improve…

This study uses special brain scans to measure and map a harmful protein called tau in people with Alzheimer's disease. Researchers will scan 160 participants already enrolled in an ongoing Alzheimer's research program to see how tau buildup relates to race, heart health risks, a…

This study aims to understand how dementia develops by tracking the memory, thinking, health, and lifestyle of 10,000 people in Scotland over many years. It will gather detailed information to identify risk factors and different patterns of disease progression. The goal is to bui…

This study is testing a new toolkit designed to help primary care doctors and nurses have better conversations with people living with dementia about their future care wishes. It will compare the toolkit to usual care across 20 clinics to see if it leads to more and higher-qualit…

This study aims to find new blood markers that can predict how quickly Alzheimer's disease will progress in a person. Researchers will follow 244 patients with early Alzheimer's for three years, taking blood samples to measure 'resilience'—the brain's ability to resist damage. Th…

This study aims to understand how early brain cell connections break down in Alzheimer's disease. Researchers will compare 20 people with Alzheimer's to 20 healthy volunteers, measuring specific substances in their blood and spinal fluid. The goal is to find biological markers th…

This study aims to follow 5000 adults over many years to understand what factors lead to brain diseases like stroke and dementia. It will track people who already have a diagnosis, are at high risk, or are currently healthy, using questionnaires and medical records. The goal is t…

This study aims to understand how early-onset Alzheimer's disease changes over time in people aged 40-64. Researchers will follow about 850 participants with and without memory problems for 2-4 years, using brain scans, memory tests, and fluid samples. The goal is to gather detai…

This research study aims to understand how non-invasive magnetic brain stimulation affects memory and brain function. It involves older adults with mild memory problems and those without cognitive issues. Participants receive repeated brain stimulation sessions while researchers …

This study aims to understand how a small, deep-brain area called the locus coeruleus is involved in the earliest stages of Alzheimer's disease. Researchers will use brain scans, eye-tracking, and simple nerve stimulation in 150 adults to see if changes in this area can predict f…

This study aims to see if a special, non-invasive eye scan can detect changes in the retina linked to dementia. Researchers will compare scans from 20 people with mild dementia to scans from people without dementia. The goal is to find new ways to identify the disease by looking …

This study aims to build a detailed picture of inherited Alzheimer's disease in China by tracking 40,000 people from affected families over time. Researchers will collect genetic, memory test, brain scan, and blood sample data to understand how the disease starts and progresses. …

This study aims to understand how the brain and body work together by measuring signals like brain waves, heart rate, and movement. Researchers will compare these signals in 100 people, including healthy individuals and those with conditions like autism spectrum disorder, ADHD, o…

This study aims to understand if COVID-19 vaccines affect brain health, specifically looking for signs of stroke or dementia. Researchers in Hong Kong will follow 500 healthy adults, comparing brain scans and memory tests from before and after vaccination to those from unvaccinat…

This study is testing a new type of brain scan to see if it can detect a specific protein called tau, which builds up in some forms of dementia. Researchers will compare scans from people with different types of Alzheimer's disease and frontotemporal dementia to scans from health…

This study aims to understand how Alzheimer's disease develops by tracking people at risk for the condition over seven years. It will follow 3,400 participants with normal memory to see if a specific blood test can predict future declines in thinking skills. The study does not te…

This study aims to see if certain proteins in the blood, related to Alzheimer's disease and brain injury, can help predict which older hospitalized patients are most likely to die or be readmitted to the hospital. Researchers will follow 400 older patients for one year after thei…

This study is testing whether improving sleep can help reduce anxiety, depression, and agitation in people with early Alzheimer's disease or memory loss. Researchers will give 150 participants either a proven sleep therapy program or a comparison activity to see if better sleep l…

This study is testing if new, non-invasive eye imaging techniques can find unique signs in the retina linked to Alzheimer's disease and other memory disorders. Researchers will compare detailed scans of the eye's blood vessels and structure in 450 people with memory complaints ag…

This study aims to better understand diseases like Alzheimer's and Parkinson's by analyzing the genes, proteins, and other molecules in people who have them. Researchers will collect blood and other samples from 1200 participants to look for patterns that could lead to new ways t…

This study aims to see if measuring certain proteins in a person's blood can accurately predict who will develop Alzheimer's disease or experience cognitive decline. Researchers will follow 1,800 adults aged 60 and older, some with memory concerns and some without, for several ye…

This study aims to build a detailed research database to help scientists develop better ways to detect, prevent, and treat Alzheimer's disease. It will enroll 1,000 adults aged 60 and older, including those with and without memory problems. Participants will be followed annually …

This early-stage study aims to see how a new version of an experimental capsule (NPT 2042) is absorbed by the body compared to the original version. It involves a small group of healthy adults who will take single doses of each capsule. The goal is to gather basic information to …

This study aims to better understand how Alzheimer's disease and Lewy body disease affect the brain over time. Researchers will observe 90 participants—including people with these conditions and healthy individuals—using brain scans, memory tests, and measurements of brain wave a…

This study aims to understand if a woman's natural hormones are connected to how she ages and her risk of developing Alzheimer's disease. It will involve about 614 women aged 60 and older, who will undergo brain scans, memory tests, and physical assessments. The goal is to gather…

This study is testing if a common B-vitamin called niacin can get into the brain and spinal fluid of people with Alzheimer's disease. Researchers will give 30 participants either a 500mg niacin pill or a placebo (sugar pill) for 60 days. The main goal is to measure how much niaci…

This study aims to understand how the brain changes and adapts in various neurological conditions and during normal aging. Researchers will use advanced, high-powered MRI scans to look at brain structure, function, and energy use in 700 participants, including people with disease…

This study aims to see if a small, contactless device placed in the bedroom can detect subtle changes in sleep patterns, walking speed, and daily activity in people with mild memory problems or early Alzheimer's disease. About 40 participants will have the device monitor them at …

This study aims to find genes linked to Alzheimer's disease by collecting genetic samples from families with multiple affected members. It is enrolling up to 10,000 participants from families with at least two living relatives diagnosed with Alzheimer's or dementia. The collected…

This study aims to understand how the body's response to stress and a person's genes might predict future memory and thinking problems in people with mild cognitive impairment, a potential early sign of Alzheimer's disease. Researchers will enroll 240 participants to undergo brie…

This study aims to create a better prediction model for how memory and thinking problems worsen over time in people with early dementia or mild cognitive impairment. Researchers will collect blood samples, perform brain scans, conduct memory tests, and gather information from clo…

This study aims to understand the early brain changes that happen before noticeable memory problems begin. Researchers will use MRI and PET brain scans, along with memory tests, to track 300 older adults with normal thinking skills over time. The goal is to find the best combinat…

This study uses special brain scans (PET and MRI) to measure amyloid plaques in people with and without Alzheimer's disease. Researchers want to understand how these plaques, along with a person's race and heart health factors, relate to memory and thinking problems. The study is…

This study creates a registry to track how new FDA-approved Alzheimer's drugs work in real-world settings across Georgia. Researchers will follow 735 Medicare patients with early Alzheimer's who receive these anti-amyloid medications during regular clinic visits. The goal is to u…

This Mayo Clinic study uses MRI scans to measure how fluid moves around the brain. Researchers want to see if fluid flow differs between healthy adults and people with conditions like Alzheimer's disease or hydrocephalus. The goal is to improve diagnosis and understanding of thes…